About Dr. Sujata Vasani
Dr. Sujata Vasani has been actively involved in the field of Medical Oncology and Haematology since the past 18 years. She has trained under the best Oncologists in the country and has previously worked at The Jaslok Hospital and Research Centre, in the Oncology Dept., with Dr. S.H. Advani and Dr. Boman Dhabhar.
She has vast experience in handling all types of malignancies in adults and children, in treating solid tumors like breast, lung, ovary, uterine, colon, gastric, pancreatic, hepatic, soft tissue tumors etc, as well as leukemias and lymphomas, all haematological malignancies, as well as benign conditions like anaemias, increase or decrease in platelets etc.
Experience
Expert Staff
In addition to being a skilled Haematologist and Oncologist, Dr Sujata is also a highly qualified Physician with over ten years experience in the field of Internal Medicine. She holds the degree of Diplomate of National Board in Internal Medicine.This results in more efficient, prompt treatment and cost savings for patients.
She has worked as a visiting physician, and as a Stem Cell and Bone Marrow Transplant Physician at the Seattle Cancer Care Alliance, USA, this is the largest and topmost ranked bone marrow transplant center in the world. Here she has had hands on experience in handling various transplants and their complications.
She has been trained to perform umbilical cord, unrelated donor, matched and unmatched, haploidentical transplants, besides all other allogenic and autologous transplants. She has also been specially trained in management of Acute and Chronic GVHD.
She has given lectures on stem cell transplantation, new developments in Medical Oncology and other Oncology malignancies to the IMA in June 2013, Aug 2013, Jan and Aug 2014, Jan 2015, 2016, 2017, 2018, 2019, to the C-Ward Medical Association in Aug 2012, to the GPA in Jan 2013, March 2013 and Feb 2014, 2015, 2016, 2017, 2018, 2019 and the Reliance Industries in Dec 2012, this was web cast to 11 centers all over India.
She has also conducted teaching sessions at Bhatia Hospital for family physicians from Aug 2012 onwards & Saifee Hospital in April 2013.
She is one of the first oncologists/hematologists in India, and the first in Mumbai to use a new monoclonal antibody, Brentuximab Vedotin, FDA approved in USA, for the treatment of refractory Hodgkin's Lymphoma. This is supposed to be a path breaking discovery and is expected to revolutionize the treatment of Hodgkin's Disease over the next few years. Her patient, a 35 year old male, is one of the first patients in the country to receive this drug at the age of 27 in 2013. He is currently 8 years post treatment and has been cured.
She is one of the first Oncologists in India to use an oral targeted therapy for Stage 4 Lung Cancer, this has increased the life expectancy of such patients from a dismal 6 months to a much longer duration, with minimal side effects and no hospitalization.
One of the first Oncologists in the country to use a new targeted therapy for Stage 4 Gastric Cancer after all current treatment lines have been exhausted, FDA approved in USA, and found to increase the survival substantially over previous therapies.
She has conducted a Clinical Trial with Reliance Life Sciences in Lymphoma, with a monoclonal antibody Rituximab, a comparative study.
Author of chapters on Hematological Emergencies, Lymphoma, Leukemias and Anemias in Dr Aspi Gowalia's textbook of Medicine and his Handbook of Medical Emergencies, 2013 edition.
Author of Basics of Stem Cell Transplant- Quarterly Medical Review For Physicians – 2017.
Dissertations:
- Cryopreservation of Platelets; (2006)
- Flow Cytometry in Minimal Residual Disease in Acute Lymphoblastic Leukemia. (2009)
Awards:
Felicitated with the prestigious J.C. Award For Young Achiever in the field of Medical Oncology and Haematology in 2016.
Felicitated by the Indo- American Society for Excellence in the field of Medical Oncology and Haematology, Stem Cell and Bone Marrow Transplants in September 2018. This felicitation was given by the American Consul General, Mr Adi Godrej, and the Union Minister Mr Nitin Gadkari.
Education & Experience
- MBBS- Bachelor of Medicine and Bachelor of Surgery
- DNB Internal Medicine
- DNB Oncology and Haematology, Stem Cell , and Bone Marrow Transplant Physician.
- Certified by the European Society of Medical Oncology ( ESMO )
- Ex Visiting Stem Cell Transplant Physician – Seattle Cancer Care Alliance, Seattle, Washington, USA. (FSCCA).
- Medical Oncologist and Haematologist
- Stem Cell and Bone Marrow Transplant Physician.
18+
Working in the field of Medical Oncology and Haematology.
- Author of chapters on Haematological Emergencies, Lymphoma, Leukemias and Anaemias in DrAspi Golwalas textbook of Medicine and his Handbook of Medical Emergencies, 2013 edition.
- Author of Basics of Stem Cell Transplant – Quarterly Medical Review For Physicians – 2017.
- Author of Cryopreservation of Platelets; (2006).
- Author of Flow Cytometry in Minimal Residual Disease in Acute Lymphoblastic Leukemia. (2009).
Books by Dr. Sujata Vasani
Author of multiple chapters in
- Dr Aspi Golwala’s Text Book of Medicine ( Practical Prescriber )
- Dr Aspi Golwala’s Handbook of Medical Emergencies.
Dr Sujata has written on a number of topics for the above books, the salient ones being on:
- Anaemia
- Lymphomas
- Leukemias
- Haematological Emergencies
These books have been widely read by medical students and have been used as teaching material in medical courses.
Author of Basics Of Stem Cell Transplants
Dr Sujata has authored a book documenting The Basics Of Stem Cell Transplants, this has helped family physicians to understand this difficult topic and its life saving use in treating blood cancers and bone marrow cancers. The book has been widely read and appreciated by multiple doctors who have benefited from the information it provides.
Author of Cryopreservation of Platelets
Dr. Sujata is the author of a Dissertation on Cryopreservation of Platelets. This book has proven of special benefit in understanding how to preserve and extend the shelf lives of life saving blood components like platelets, which are essential products required when a patient is bleeding.
Flow Cytometry to detect Minimal Residual Disease in Acute Leukemia
Dr. Sujata is the author of a Dissertation on the use of Flow Cytometry to detect Minimal Residual Disease in Acute Leukemia. This technique has helped greatly in improving the cure rates in Leukemia patients, by detecting microscopic leukemic cells and eliminating them before they trigger a relapse. In turn this has ensured longer survival rates for patients suffering from this lethal disease.
Why Trust Us
Dr. Sujata has a strong track record of successfully treating all solid tumors, blood cancers, and other blood disorders. Our team takes the time to fully explain treatment options and address any concerns. Most importantly, we are a compassionate and caring team that makes patients feel more at ease and trust that they are in good hands.
High Quality Labs
Essentially because they play a crucial role in accurately diagnosing and monitoring cancer and other medical conditions.
Unmatched Expertise
Ensuring that patients receive the highest quality medical care and treatment from highly trained and experienced professionals.
Precise Diagnosis
Allowing us to prepare the most effective and personalized treatment plan to be developed for each patient.
Qualified Staff
Ensuring that patients receive high quality medical care and support from knowledgeable and compassionate professionals.
Dr. Sujata's
Specializations
Specialized treatments are often used in combination with traditional treatments such as surgery, chemotherapy, and radiation therapy to improve outcomes and reduce the risk of cancer recurrence.
Solid Tumors
A solid tumor is an abnormal mass of cells that grows uncontrollably in the body and can be benign or cancerous.
Blood Cancer
Blood cancers occur when abnormal blood cells expand uncontrollably, interfering with normal blood cells' ability to fight infection and make new cells.
Lung Cancer
In very simple terms, lung cancer happens when multiple genetic changes happen in the normal respiratory epithelium, which is part of the lung parenchyma.
Prostrate Cancer
Prostate cancer is a disease in which malignant cells form in the tissues of the prostate gland.
Ovarian Cancer
Ovarian cancer is a type of cancer that affects the ovaries, which are small, almond-shaped organs located on either side of the uterus in a woman's pelvis
Colon Cancer
Colon cancer is a type of cancer that affects the large intestine (colon) and can sometimes spread to other parts of the body.
Uterine Cancer
A condition known as uterine cancer occurs when cancerous cells develop in the uterus' tissues (womb).
Other Cancer
Find comprehensive information on various types of cancer and their treatments, chemotherapy, radiation therapy, and more.
Specialized breast cancer clinic
Estimated number of new cases in 2020, World, both sexes, all ages
No Data Found
Achievements
Dr. Sujata was among the first oncologists/hematologists in India, and the first in Mumbai, to use a new monoclonal antibody, Brentuximab Vedotin, to treat refractory Hodgkin lymphoma.
She is one of the first oncologists in India to use an oral targeted therapy for stage 4 lung cancer. This has increased the life expectancy of such patients from a dismal 6 months to a much longer duration with minimal side effects and no hospitalization.
One of the country's first oncologists to use a new targeted therapy for stage 4 gastric cancer after all other treatment options had been exhausted, it was recently FDA approved in the United States and found to significantly increase survival over previous therapies.
Best Cancer Treatment Starts with a Consultation
Patient Case studies
Case studies provide valuable insights into the treatment and management of individual cancer patients, informing oncologists’ decision-making and helping to improve care and outcomes for all patients. They also inform clinical guidelines and best practices, benefiting all cancer patients
Testimonials
Frequently Asked Questions
A Haemato- Oncologist is a Haematologist and a Medical Oncologist. A Haematologist treats all blood related disorders like anaemia, low platelets, high platelets, low and high WBC counts, thalassaemia, sickle cell anaemia etc, these are all benign blood disorders.In addition, a Haematologist also treats all blood and bone marrow cancers like leukemias, all lymphomas & multiple myeloma.
In the 21st century, we have access to advanced technology that has led to the development of non-invasive treatment options for many types of cancer. These treatments include targeted therapy, oral tablets, immunotherapy, and chemotherapy. For some cancers such as leukemia, lymphoma, and myeloma, surgery is not always required. Additionally, clinical trials have shown that early-stage breast cancer can potentially be cured with chemotherapy and radiation alone. Today, each cancer patient receives personalized care tailored to their specific cancer’s molecular profile.
Survival rates for cancer patients has increased substantially over the past few decades. On an average, 80% of patients would survive their cancer if they receive the correct treatment promptly. The stage at which the cancer is detected determines the survival. Early-stage cancers can be cured, advanced stage can be controlled. Cancer treatment has improved in leaps and bounds in the 21st century. In the 60s, 70s, 80s, treatment options for cancer were mostly surgical, chemotherapy drugs were limited, personalised care was an unknown term- one size fits all policy was followed. This meant that every cancer received the same treatment irrespective of the stage. This reflected in the survival rates which were poor and a cancer diagnosis was a death sentence.
With the personalised and customised cancer care that is administered, post treatment care and rehabilitation for cancer patients is required only to a limited extent. Modern chemotherapy & targeted therapies are extremely well tolerated with minimal side effects. The patient leads a normal life while his treatment is ongoing. He can continue with his daily routine. What is required on occasion is counselling for the patient to overcome their fear regarding their cancer returning and staying mentally strong. The treating Medical Oncologist is the best person to provide this support.
Yes, cancer support groups & counselling services are available depending on the type of cancer the patient is suffering from. Every cancer has a separate support group. Multiple counselling services can assist in relieving the mental stress & strain the cancer patients and their families endure.
The new cancer treatments have minimal side-effects and are extremely well tolerated. The customised care given ensures that the patient faces no major issues during the therapy. Different drugs have different side-effects. Appetite loss, mild weakness, vulnerability to infection are some of the problems that can be encountered. However, these can be easily tackled and are usually not a cause for concern.
As an Honorary Medical Oncologist and Hematologist, I visit several hospitals that offer the latest and most advanced cancer care. Each patient receives personalized and customized treatment that follows international guidelines. Both daycare and inpatient services are available, and a trained oncology resident and chemotherapy nurse are on call 24/7 to attend to cancer patients. The drugs used are of the highest quality and are provided at cost-effective rates
The follow-up plan after treatment for ovarian cancer depends on the type of treatment received and the stage of the cancer. For example, if the patient received oral or intravenous therapy, targeted therapy, chemotherapy, or a combination of these treatments. Additionally, if the treatment was curative or meant to control the cancer. Typically, patients are scheduled for check-ups with blood tests and scans every three months for the first two years after treatment. This interval then increases to every six months for the next three years. After five years post-treatment, a yearly check-up is generally sufficient. However, if a patient is still receiving ongoing cancer treatment, then follow-up appointments every three months are typically continued.
At any given time, multiple clinical trials and research studies are ongoing in various cancers worldwide. As per your age, the type of your cancer and the stage you are detected in, you could definitely be eligible for a few of these studies. Your treating Medical Oncologist is the appropriate person to guide you regarding participation in clinical trials.
Subscribe To Our Newsletter
Stay in touch with us to get latest news and special offers.
